International Space Station

Two of RNAssist’s molecular stabilsation reagents will be taken to the International Space Station

June 01, 20230 min read

We are delighted that we can make a small contribution to the important work of Dr. Scott Tighe, Technical Director at the Advanced Genomics Lab at the University of Vermont, NASA-ISS uTitan Payload developer and Group leader Extreme Microbiome Project. 

 In December 2023, two of RNAssist’s molecular stabilisation reagents will be taken to the International Space Station (ISS) on SpaceX Dragon SpX-29 where they will be tested on microbial samples as part of a larger study in collaboration with NASA.

Back to Blog


RNAssist technology supports a wide range of life science applications, including tissue fixation and dissociation, single-cell multiomics (scRNA-seq, CITE-seq), and virus inactivation and transport for enhanced diagnostic testing.

Follow us on LinkedIn

© RNAssist | www.RNAssist.com